Skip to main content
Figure 2 | Orphanet Journal of Rare Diseases

Figure 2

From: Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support

Figure 2

Adherence to treatment among CHH men. Patient-reported longest duration off treatment (n = 93). All men had been on treatment for at least 12 months. Only 26% (24/93) of men reported never having a gap in treatment (white bar). In total, 37% (34/93) had a lapse in treatment of more than1 year.

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172